Mapping of Pro-Equity Interventions Proposed by Immunisation Programs in Gavi Health Systems Strengthening Grants

LOOK AT THIS IF YOU'RE INTERESTED IN:

Analyzing different interventions implemented in Gavi-supported countries to improve immunisation equity.

HOW YOU CAN USE THIS MATERIAL:

The findings can help immunisation programme managers and policymakers identify specific interventions on which to focus efforts to better reach zero-dose children and missed communities moving forward.

OVERVIEW:

There is still an important lack of knowledge about which interventions can be implemented to best reach zero-dose children, how much they cost, and how to sustain progress. Understanding which interventions are already being implemented is one step towards building this evidence base. This study mapped pro-equity strategies implemented in thirteen Gavi-supported countries through review of Joint Appraisal (JA) reports from 2016 to 2019 to improve immunisation equity and to understand how these investments can help us prioritise interventions moving forward.

You May Also Like

Scoping Review of Current Costing Literature on Interventions to Reach Zero-Dose Children in Low- and Middle-Income Countries

A study in Vaccines analyzes the costs and effectiveness of interventions aimed at reaching zero-dose children—those who have not received any routine vaccinations—in low- and middle-income countries (LMICs). The research evaluates strategies such as mobile outreach, community engagement, and health system strengthening, highlighting their cost-effectiveness in improving immunisation coverage. The findings suggest that tailored, context-specific … Read More

Read

Socioeconomic-related inequities in child immunisation: horizontal and vertical dimensions for policy insights

A study in Health Economics Review investigates the economic and equity impacts of expanding immunisation programs in low- and middle-income countries (LMICs), focusing on the cost-effectiveness of introducing new vaccines. The research highlights that while scaling up immunisation efforts requires significant investment, the long-term benefits—such as reduced disease burden, healthcare savings, and improved productivity—justify the … Read More

Read